These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 36476965

  • 1. Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae.
    Davido B, Crémieux AC, Vaugier I, Gatin L, Noussair L, Massias L, Laurent F, Saleh-Mghir A.
    Int J Antimicrob Agents; 2023 Jan; 61(1):106702. PubMed ID: 36476965
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of ceftazidime/avibactam in various combinations for the treatment of experimental osteomyelitis in rabbits caused by OXA-48-/ESBL-producing Escherichia coli.
    Davido B, Crémieux AC, Vaugier I, De Truchis P, Hamami K, Laurent F, Saleh-Mghir A.
    J Antimicrob Chemother; 2023 May 03; 78(5):1211-1218. PubMed ID: 36897329
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
    Crémieux AC, Dinh A, Nordmann P, Mouton W, Tattevin P, Ghout I, Jayol A, Aimer O, Gatin L, Verdier MC, Saleh-Mghir A, Laurent F.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2666-2675. PubMed ID: 31263884
    [Abstract] [Full Text] [Related]

  • 4. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.
    Huang Y, Sokolowski K, Rana A, Singh N, Wang J, Chen K, Lang Y, Zhou J, Kadiyala N, Krapp F, Ozer EA, Hauser AR, Li J, Bulitta JB, Bulman ZP.
    Antimicrob Agents Chemother; 2021 Aug 17; 65(9):e0069221. PubMed ID: 34152820
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.
    Zhang W, Guo Y, Li J, Zhang Y, Yang Y, Dong D, Zhu D, He P, Hu F.
    Antimicrob Resist Infect Control; 2018 Aug 17; 7():142. PubMed ID: 30479755
    [Abstract] [Full Text] [Related]

  • 6. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y.
    Clin Microbiol Infect; 2020 Jan 17; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [Abstract] [Full Text] [Related]

  • 7. In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
    Gaibani P, Lewis RE, Volpe SL, Giannella M, Campoli C, Landini MP, Viale P, Re MC, Ambretti S.
    Int J Infect Dis; 2017 Dec 17; 65():1-3. PubMed ID: 28951106
    [Abstract] [Full Text] [Related]

  • 8. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.
    Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.
    Antimicrob Agents Chemother; 2018 Mar 17; 62(3):. PubMed ID: 29263067
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.
    Tumbarello M, Trecarichi EM, Corona A, De Rosa FG, Bassetti M, Mussini C, Menichetti F, Viscoli C, Campoli C, Venditti M, De Gasperi A, Mularoni A, Tascini C, Parruti G, Pallotto C, Sica S, Concia E, Cultrera R, De Pascale G, Capone A, Antinori S, Corcione S, Righi E, Losito AR, Digaetano M, Amadori F, Giacobbe DR, Ceccarelli G, Mazza E, Raffaelli F, Spanu T, Cauda R, Viale P.
    Clin Infect Dis; 2019 Jan 18; 68(3):355-364. PubMed ID: 29893802
    [Abstract] [Full Text] [Related]

  • 10. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M, Castillo-Polo JA, Cordero DG, Pérez-Viso B, García-Castillo M, Saez de la Fuente J, Morosini MI, Cantón R, Ruiz-Garbajosa P.
    J Clin Microbiol; 2022 Mar 16; 60(3):e0224521. PubMed ID: 35107303
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort.
    Castón JJ, Gallo M, García M, Cano A, Escribano A, Machuca I, Gracia-Aufinger I, Guzman-Puche J, Pérez-Nadales E, Recio M, Muñoz M, Martínez-Martínez L, Torre-Cisneros J, Spanish Network for Research in Infectious Diseases (REIPI).
    Int J Antimicrob Agents; 2020 Sep 16; 56(3):106075. PubMed ID: 32629116
    [Abstract] [Full Text] [Related]

  • 12. Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient.
    Gaibani P, Gatti M, Rinaldi M, Crovara Pesce C, Lazzarotto T, Giannella M, Lombardo D, Amadesi S, Viale P, Pea F, Ambretti S.
    Int J Infect Dis; 2021 Dec 16; 113():213-217. PubMed ID: 34656787
    [Abstract] [Full Text] [Related]

  • 13. In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae.
    Romanelli F, De Robertis A, Carone G, Dalfino L, Stufano M, Del Prete R, Mosca A.
    New Microbiol; 2020 Jul 16; 43(3):136-138. PubMed ID: 32596740
    [Abstract] [Full Text] [Related]

  • 14. [In vitro activity of ceftazidime-avibactam combined with colistin against extensively drug-resistant Pseudomonas aeruginosa].
    Mei Q, Geng S, Fang X, He Y, Liu L, Xu M, Zhu C, Pan A.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct 16; 31(10):1212-1218. PubMed ID: 31771717
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model.
    Drusano GL, Shields RK, Mtchedlidze N, Nguyen MH, Clancy CJ, Vicciarelli M, Louie A.
    Antimicrob Agents Chemother; 2019 Aug 16; 63(8):. PubMed ID: 31160285
    [Abstract] [Full Text] [Related]

  • 16. Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practice.
    Eren-Kutsoylu OÖ, Ceylan-Çimendağ H, Sari-Kaygisiz AN, Tanriverdi ES, Özbek ÖA, Öktem IMA, Otlu B, Avkan-Oğuz V.
    J Infect Dev Ctries; 2024 Jul 29; 18(7):1020-1025. PubMed ID: 39078779
    [Abstract] [Full Text] [Related]

  • 17. Increased Expression and Amplification of blaKPC-2 Contributes to Resistance to Ceftazidime/Avibactam in a Sequence Type 11 Carbapenem-Resistant Klebsiella pneumoniae Strain.
    Li X, Zhang J, Yang C, Li J, Wang J, Huang W, Zeng L, Liang X, Long W, Zhang X.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0095522. PubMed ID: 35900090
    [Abstract] [Full Text] [Related]

  • 18. Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering.
    Barnes MD, Winkler ML, Taracila MA, Page MG, Desarbre E, Kreiswirth BN, Shields RK, Nguyen MH, Clancy C, Spellberg B, Papp-Wallace KM, Bonomo RA.
    mBio; 2017 Oct 31; 8(5):. PubMed ID: 29089425
    [Abstract] [Full Text] [Related]

  • 19. Implementation of Chromatic Super CAZ/AVI® medium for active surveillance of ceftazidime-avibactam resistance: preventing the loop from becoming a spiral.
    Bianco G, Boattini M, Comini S, Leone A, Bondi A, Zaccaria T, Cavallo R, Costa C.
    Eur J Clin Microbiol Infect Dis; 2022 Sep 31; 41(9):1165-1171. PubMed ID: 35933457
    [Abstract] [Full Text] [Related]

  • 20. Resistance to ceftazidime-avibactam in a KPC-2-producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25.
    Findlay J, Poirel L, Bouvier M, Gaia V, Nordmann P.
    Eur J Clin Microbiol Infect Dis; 2023 May 31; 42(5):639-644. PubMed ID: 36877262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.